Universität zu Köln

Koehler, Philipp ORCID: 0000-0002-7386-7495, Mellinghoff, Sibylle C., Lagrou, Katrien, Alanio, Alexandre, Arenz, Dorothee, Hoenigl, Martin ORCID: 0000-0002-1653-2824, Koehler, Felix C., Lass-Floerl, Cornelia, Meis, Jacques F., Richardson, Malcolm and Cornely, Oliver A. (2019). Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology. J. Antimicrob. Chemother., 74 (6). S. 1704 - 1713. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091

Full text not available from this repository.

Abstract

Background: Mucormycosis is a life-threatening infection in immunocompromised patients and in haematological malignancy patients in particular. Objectives: Our aim was to develop and evaluate a scoring tool to measure adherence to current guidelines for mucormycosis. Methods: Current guidelines of scientific societies on mucormycosis management were reviewed. We assembled diagnostic, treatment and follow-up milestones and designed the EQUAL Mucormycosis Score. The EQUAL Mucormycosis Score was evaluated in the ECMM Excellence Centres. Results: An 18-item tool with one to three points per item resulted in a maximum achievable score depending on disease complexity and ranging from 25 to 32 points. Given variable patient disease course, the diagnostic score is higher in patients with positive fungal culture and biopsy, thus reflecting more decision points and higher management complexity. Eleven patients from two centres were included during the study period. A total of 200 EQUAL Mucormycosis Score points were achieved, which is 62.7% of the maximum EQUAL Mucormycosis Score of 319 points achievable in that cohort (median 18 points, range 7-27). The total score accomplished for diagnostic procedures was 112 of 165 points (67.9%), for first-line treatment 54 of 88 (61.4%) and for follow-up management 34 of 66 points (51.5%). Conclusions: The EQUAL Mucormycosis Score quantitates adherence to current guideline recommendations for mucormycosis management. With 62.7% of maximum achievable score points, a first result is obtained that may serve as a reference for future evaluations. It remains to be shown whether guideline adherence and mortality rates correlate.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Koehler, Philipp UNSPECIFIED orcid.org/0000-0002-7386-7495 UNSPECIFIED Mellinghoff, Sibylle C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Lagrou, Katrien UNSPECIFIED UNSPECIFIED UNSPECIFIED Alanio, Alexandre UNSPECIFIED UNSPECIFIED UNSPECIFIED Arenz, Dorothee UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoenigl, Martin UNSPECIFIED orcid.org/0000-0002-1653-2824 UNSPECIFIED Koehler, Felix C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Lass-Floerl, Cornelia UNSPECIFIED UNSPECIFIED UNSPECIFIED Meis, Jacques F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Richardson, Malcolm UNSPECIFIED UNSPECIFIED UNSPECIFIED Cornely, Oliver A. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-138435
DOI:	10.1093/jac/dkz051
Journal or Publication Title:	J. Antimicrob. Chemother.
Volume:	74
Number:	6
Page Range:	S. 1704 - 1713
Date:	2019
Publisher:	OXFORD UNIV PRESS
Place of Publication:	OXFORD
ISSN:	1460-2091
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language INFECTIONS; GUIDELINES; MALIGNANCY; LEUKEMIA Multiple languages Infectious Diseases; Microbiology; Pharmacology & Pharmacy Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/13843